Cargando…

Fibroblast growth factor 21 levels and liver inflammatory biomarkers in obese subjects after weight loss

INTRODUCTION: Previous studies have hypothesized fibroblast growth factor 21 (FGF-21) as a potential biomarker of the inflammation associated with liver diseases, which is also receiving considerable attention for its potential application concerning the management of obesity and co-morbidities. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantero, Irene, Abete, Itziar, Bullón-Vela, Vanessa, Crujeiras, Ana B., Casanueva, Felipe F., Zulet, M. Angeles, Martinez, J. Alfredo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826683/ https://www.ncbi.nlm.nih.gov/pubmed/35154523 http://dx.doi.org/10.5114/aoms/98948

Ejemplares similares

Fruit Fiber Consumption Specifically Improves Liver Health Status in Obese Subjects under Energy Restriction
por: Cantero, Irene, et al.
Publicado: (2017)

Changes in lysophospholipids and liver status after weight loss: the RESMENA study
por: Cantero, Irene, et al.
Publicado: (2018)

Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects
por: Lopez-Legarrea, P, et al.
Publicado: (2014)

Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity
por: Sajoux, Ignacio, et al.
Publicado: (2019)

Chronologically scheduled snacking with high-protein products within the habitual diet in type-2 diabetes patients leads to a fat mass loss: a longitudinal study
por: Navas-Carretero, Santiago, et al.
Publicado: (2011)

Association between Different Animal Protein Sources and Liver Status in Obese Subjects with Non-Alcoholic Fatty Liver Disease: Fatty Liver in Obesity (FLiO) Study
por: Recaredo, Gregorio, et al.
Publicado: (2019)

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial
por: Marin-Alejandre, Bertha Araceli, et al.
Publicado: (2019)

Interplay of Glycemic Index, Glycemic Load, and Dietary Antioxidant Capacity with Insulin Resistance in Subjects with a Cardiometabolic Risk Profile
por: Galarregui, Cristina, et al.
Publicado: (2018)

Association of the SH2B1 rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2020)

DNA Hypermethylation of the Serotonin Receptor Type-2A Gene Is Associated with a Worse Response to a Weight Loss Intervention in Subjects with Metabolic Syndrome
por: Perez-Cornago, Aurora, et al.
Publicado: (2014)

Association between Sleep Disturbances and Liver Status in Obese Subjects with Nonalcoholic Fatty Liver Disease: A Comparison with Healthy Controls
por: Marin-Alejandre, Bertha Araceli, et al.
Publicado: (2019)

Factors Associated with Sarcopenia and 7-Year Mortality in Very Old Patients with Hip Fracture Admitted to Rehabilitation Units: A Pragmatic Study
por: Malafarina, Vincenzo, et al.
Publicado: (2019)

Genetic predictors of weight loss in overweight and obese subjects
por: Lamiquiz-Moneo, Itziar, et al.
Publicado: (2019)

Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial
por: Lopez-Legarrea, Patricia, et al.
Publicado: (2013)

Predictive Value of Serum Ferritin in Combination with Alanine Aminotransferase and Glucose Levels for Noninvasive Assessment of NAFLD: Fatty Liver in Obesity (FLiO) Study
por: Galarregui, Cristina, et al.
Publicado: (2020)

Urinary Resveratrol Metabolites Output: Differential Associations with Cardiometabolic Markers and Liver Enzymes in House-Dwelling Subjects Featuring Metabolic Syndrome
por: Bullón-Vela, Vanessa, et al.
Publicado: (2020)

Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later?
por: Izquierdo, Andrea G., et al.
Publicado: (2019)

Weight Loss and Hypertension in Obese Subjects
por: Fantin, Francesco, et al.
Publicado: (2019)

Energy Expenditure Improved Risk Factors Associated with Renal Function Loss in NAFLD and MetS Patients
por: Abbate, Manuela, et al.
Publicado: (2021)

Implication of miR-612 and miR-1976 in the regulation of TP53 and CD40 and their relationship in the response to specific weight-loss diets
por: Garcia-Lacarte, Marcos, et al.
Publicado: (2018)

Effects of an interdisciplinary weight loss program on fibroblast growth factor 21 and inflammatory biomarkers in women with overweight and obesity
por: Dâmaso, Ana Raimunda, et al.
Publicado: (2021)

Oxidative Stress Induced by Excess of Adiposity Is Related to a Downregulation of Hepatic SIRT6 Expression in Obese Individuals
por: Carreira, Marcos C., et al.
Publicado: (2018)

SERPINE1, PAI-1 protein coding gene, methylation levels and epigenetic relationships with adiposity changes in obese subjects with metabolic syndrome features under dietary restriction
por: Lopez-Legarrea, Patricia, et al.
Publicado: (2013)

Cocoa extract intake for 4 weeks reduces postprandial systolic blood pressure response of obese subjects, even after following an energy-restricted diet
por: Ibero-Baraibar, Idoia, et al.
Publicado: (2016)

Relationship of visceral adipose tissue with surrogate insulin resistance and liver markers in individuals with metabolic syndrome chronic complications
por: Bullón-Vela, Vanessa, et al.
Publicado: (2020)

Adherence to Mediterranean Diet and NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
por: Montemayor, Sofía, et al.
Publicado: (2022)

miR-1185-1 and miR-548q Are Biomarkers of Response to Weight Loss and Regulate the Expression of GSK3B
por: Garcia-Lacarte, Marcos, et al.
Publicado: (2019)

Effects of Weight Loss on FGF-21 in Human Subjects: An Exploratory Study
por: Headland, Michelle L., et al.
Publicado: (2019)

Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss
por: Barja-Fernandez, S, et al.
Publicado: (2014)

Effect of Dietary and Lifestyle Interventions on the Amelioration of NAFLD in Patients with Metabolic Syndrome: The FLIPAN Study
por: Montemayor, Sofía, et al.
Publicado: (2022)

Reducing Metabolic Syndrome through a Group Educational Intervention Program in Adults with Obesity: IGOBE Program
por: Tejera, Cristina, et al.
Publicado: (2022)

Ultrasound/Elastography techniques, lipidomic and blood markers compared to Magnetic Resonance Imaging in non-alcoholic fatty liver disease adults
por: Cantero, Irene, et al.
Publicado: (2019)

Starches, Sugars and Obesity
por: Aller, Erik E. J. G., et al.
Publicado: (2011)

Epigenetic Regulation of Processes Related to High Level of Fibroblast Growth Factor 21 in Obese Subjects
por: Płatek, Teresa, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease Is Associated with Kidney Glomerular Hyperfiltration in Adults with Metabolic Syndrome
por: Abbate, Manuela, et al.
Publicado: (2021)

Albuminuria Is Associated with Hepatic Iron Load in Patients with Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome
por: Abbate, Manuela, et al.
Publicado: (2021)

Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2021)

Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus
por: Goday, A, et al.
Publicado: (2016)

Anti-obesity activity of OBEX is regulated by activation of thermogenesis and decreasing adiposity gain
por: Carreira, Marcos C., et al.
Publicado: (2018)

Gender Dimorphism in Hepatic Carcinogenesis-Related Gene Expression Associated with Obesity as a Low-Grade Chronic Inflammatory Disease
por: Izquierdo, Andrea G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k2c9g6gs0dqer6dr82jnupsl3b